Noxafil & Product use in unapproved indication

15.0%

of users reported Product use in unapproved indication

66.7%

also reported Severe reaction

68.4%

are men

Severe reaction

66.7%

Hospitalization

16.7%

Death

8.3%

Life-threatening condition

8.3%

Noxafil: general information

0 - 9 years

4.8%

10 - 19 years

4.8%

20 - 29 years

5.9%

30 - 39 years

7.3%

40 - 49 years

12.7%

50 - 59 years

21.5%

60 - 69 years

25.9%

70 - 79 years

17.2%